Dr. Louise Demers

Professor

Build a Statement of Purpose

Generate a tailored SOP for Dr. Louise Demers. Improve your application with a focused, well-structured draft.

Biography

Louise Demers is a Full Professor and Director at the School of Rehabilitation at the Université de Montréal, where she also serves as the Associate Vice-Dean of Health Sciences within the Faculty of Medicine. She is an internationally renowned researcher with a deep focus on geriatric rehabilitation, outcome measurement, assistive technology, and caregiver burden. Demers has authored over 80 peer-reviewed articles and has been involved in multiple research projects funded by agencies including the Canadian Institutes of Health Research and the Quebec Research Fund. She is a member of the International Consortium of Outcomes Measures Research and has held several prestigious awards throughout her career, including the Career Investigator Award from the Quebec Research Fund. Her research interests include gerontechnology, caregiver support, and the social participation of older adults within the community. Louise's educational background includes a Postdoctoral Fellowship in Epidemiology and Biostatistics from McGill University and a Doctorate in Biomedical Sciences from the Université de Montréal, among other qualifications. Her commitment to advancing the field of geriatric rehabilitation and her contributions to teaching and research supervision have made her a key figure in her discipline.

Research Interests

Requirements for Université de Montréal

Doctorate Program
Requirements
GPA Requirement
Required:3.3
TOEFL
Listening
Required:20
Reading
Required:20
Writing
Required:20
Speaking
Required:20
Total
Required:90
Prerequisites
MSc in Pharmacology or equivalent Research supervisor confirmation
Application Checklist
  • Transcripts
  • Birth certificate
  • Curriculum Vitae
  • Proof of French proficiency (B2/C1)
Specialization Notes

Department of Pharmacology and Physiology - Research intensive with options in Neuropharmacology and Pharmacogenomics.